From: Governance and pharmacovigilance in Brazil: a scoping review
 | STARLITE principles |
---|---|
S | Selective sampling strategy: Articles selected from pharmacy, health, political science, and the social sciences databases |
T | All types of studies were included (policy papers, qualitative studies, dissertations) |
A | Approaches: Subject searching, citation searching, hand-searching, internet searching |
R | Range (No restrictions): to the beginning of each database—to November 18, 2013 |
L | No Limits |
I | Inclusion: Global actors and pharmacovigilance, regulatory governance, accountability and transparency in Brazil; Exclusion: Studies describing 1) vaccines, herbals or animal studies; 2) pre-market studies (phase I, II, and III); 3) pharmaceutics methods; 4) randomized controlled trials or observational studies pertaining to therapeutics or characterizing drug-specific ADRs or 5) did not describe pharmacovigilance in Brazil |
T | Terms (See Table 1) |
E | Electronic sources: Ovid MEDLINE(R), Ovid OLDMEDLINE(R), Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid Healthstar, Embase Classic + Embase, International Pharmaceutical Abstracts, International Political Science Abstract, Journals@Ovid Full Text, Embase, LILACS, PubMed, EBSCO, SciELO, GOOGLE Scholar |